Harm reduction funding around the world is stalling. By extension, harm reductionists in Eastern Europe and Central Asia (EECA) are…
As the international cocaine supply becomes increasingly risky, most people who use the drug are in favor of a regulated,…
On May 8, pharmaceutical company Gilead quietly announced that it will relinquish its exclusive patent on Truvada for HIV pre-exposure…
Funding for harm reduction interventions in Maine received a much-needed boost on February 6. Newly-elected Governor Janet Mills signed an executive…
The fight for universal access to PrEP medication for HIV prevention was picked up by Vermont Senator and presidential hopeful…
It's been less than two weeks since the US Department of Justice joined a string of lawsuits against Indivior—the maker…
In the hyper-commodifying cannabis industry, Mary Pryor of New York City is raising her voice for people of color to…
In April 2010, Sean tested positive for the hepatitis C virus (HCV) in Seattle’s Harborview Medical Center. Aged 37, he…
In the lucrative but hit-and-miss opioid use disorder treatment field, buprenorphine is one medication that has demonstrated outstanding efficacy. It’s…
Many of the policies peddled by the Trump administration sound like a broken record. A case in point is its…